Molecular Probes

Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay

Retrieved on: 
Donnerstag, Dezember 16, 2021
Health, FDA, Medical Devices, Infectious Diseases, Research, Science, Biotechnology, RPP, Anxiety, BMB, Autoimmune disease, Solution, Degenerative disease, FDA, US, Allergy, Influenza, COVID-19 testing, Infection, Severe acute respiratory syndrome coronavirus 2, Physician, Diagnosis, Molecular Probes, Immunochemistry, IVD, COVID-19, Nomenclature codes, Emergency Use Authorization, EUA, CE marking, Hair, Patient, Stanford University v. Roche Molecular Systems, Inc., Laboratory, Virus, Urinary tract infection, RSV, GPP, Medical degree, View, Vaccine, Medical device, H3

Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US FDA for its BioCode CoV-2 Flu Plus Assay.

Key Points: 
  • Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US FDA for its BioCode CoV-2 Flu Plus Assay.
  • The BioCode CoV-2 Flu Plus Assay is Applied BioCodes third EUA authorization from the US FDA for COVID-19 testing.
  • Applied BioCode previously received FDA EUA authorization for the BioCode SARS CoV-2 Assay and for pooling of up to 5 samples for that assay.
  • BioCode CoV-2 Flu Plus Assay builds on the existing portfolio of high-throughput syndromic assays from Applied BioCode including the FDA 510(k) cleared BioCode Respiratory Pathogen Panel (17 targets), FDA 510(k) cleared BioCode Gastrointestinal Pathogen Panel (17 targets), and its stand-alone EUA authorized BioCode SARS-CoV-2 Assay.

Applied BioCode Launches 28 New Fungal Analyte Specific Reagents in the US

Retrieved on: 
Montag, November 22, 2021
Biotechnology, Technology, FDA, Health, General Health, Pharmaceutical, Other Technology, Medical Devices, Research, Infectious Diseases, Science, Patient, CFR, Molecular Probes, US Foods, Technology, Hair, Hospital, Autoimmune disease, Diagnosis, Medical degree, IVD, ASR, VHA, BMB, Ligand, Department, Research, Nomenclature codes, Organization, Analyte-specific reagent, FDA, Allergy, Fungus, Infection, Immunochemistry, United States Department of Veterans Affairs, Clinical Laboratory, CLIA, Veterans Health Administration, ASRS, Food, LDT, Medical device, Vaccine

Applied BioCode announced today that it has released 28 Fungal Analyte Specific Reagents (ASRs) for use in molecular tests.

Key Points: 
  • Applied BioCode announced today that it has released 28 Fungal Analyte Specific Reagents (ASRs) for use in molecular tests.
  • These ASR products utilize the companys proprietary Barcoded Magnetic Bead (BMB) technology for specific detection of targeted organisms.
  • Launching Fungal ASRs brings our proprietary BMB technology closer towards the majority of hospitals and commercial laboratories in the US.
  • Applied BioCode also partners with a variety of diagnostic companies with applications that include the infectious disease, autoimmune disease, allergy, gut microbiome, and veterinary markets.

Thermo Fisher Scientific to Support mRNA-based Vaccine Candidate Production for BioNTech

Retrieved on: 
Dienstag, Februar 26, 2019
Companies, Economy of the United States, Industries, Thermo Fisher Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Thermo, Life Technologies, Molecular Probes

Under the agreement, Thermo Fisher will supply nucleotides, enzymes and other critical raw materials to support BioNTech's messenger RNA (mRNA) manufacturing platform.

Key Points: 
  • Under the agreement, Thermo Fisher will supply nucleotides, enzymes and other critical raw materials to support BioNTech's messenger RNA (mRNA) manufacturing platform.
  • The four-year, nonexclusive licensing and supply agreement gives BioNTech rights to use Thermo Fisher's technologies as part of its clinical and commercial manufacturing processes.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.

Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.

Retrieved on: 
Montag, Oktober 29, 2018
Technology, Economy of the United States, Thermo Fisher Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Thermo, Science and technology, Life Technologies, Molecular Probes

"Thermo Fisher Scientific remains an important employer in our state and a significant driver of economic growth, particularly in Frederick County where manufacturing is the number one source of jobs," said Maryland Lt.

Key Points: 
  • "Thermo Fisher Scientific remains an important employer in our state and a significant driver of economic growth, particularly in Frederick County where manufacturing is the number one source of jobs," said Maryland Lt.
  • Newly expanded by more than 190,000 square feet, the center will serve as the North American hub for Thermo Fisher's life sciences business.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.